Nephros (NEPH) Retained Earnings (2010 - 2026)
Nephros (NEPH) posted quarterly Retained Earnings of -$143.0 million for Q1 2026, up 0.54% year-over-year from -$142.2 million in Q1 2025, and down 193.26% quarter-over-quarter from $153.3 million in Q4 2025.
Nephros (NEPH) Retained Earnings (2010 - 2026) Analysis & Trends
Nephros' Retained Earnings history runs 17 years deep, the most recent figure standing at -$143.0 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 0.54% year-over-year to -$143.0 million; the TTM figure through Mar 2026 stood at -$143.0 million (up 0.54% YoY), while the FY2025 annual figure was $153.3 million, up 206.23% from the prior year.
- Retained Earnings for Q1 2026 stood at -$143.0 million, down from $153.3 million in the prior quarter.
- The five-year high for Retained Earnings was $153.3 million in Q4 2025, with the low at -$144.9 million in Q2 2024.
- The 5-year median for Retained Earnings is -$143.1 million (2023), against an average of -$73.5 million.
- Peak annual rise in Retained Earnings reached 231795.31% in 2022, while the deepest fall reached 215225.76% in 2022.
- Nephros' Retained Earnings stood at $148.4 million in 2022, then plunged by 197.3% to -$144.4 million in 2023, then climbed by 0.05% to -$144.3 million in 2024, then surged by 206.23% to $153.3 million in 2025, then sank by 193.26% to -$143.0 million in 2026.
- Business Quant data shows NEPH's Retained Earnings at -$143.0 million in Q1 2026, $153.3 million in Q4 2025, and $153.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.84 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 17.51 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 7.26 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 11.40 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.92 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 7.70 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 13.81 Bn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 153.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 153.76 Mn |
| Mar 31, 2026 | -143.00 Mn |
| Dec 31, 2025 | 153.33 Mn |
| Sep 30, 2025 | 153.20 Mn |
| Jun 30, 2025 | -143.54 Mn |
| Mar 31, 2025 | -143.77 Mn |
| Dec 31, 2024 | -144.33 Mn |
| Sep 30, 2024 | -144.70 Mn |
| Jun 30, 2024 | -144.90 Mn |
| Mar 31, 2024 | 152.75 Mn |
| Dec 31, 2023 | -144.41 Mn |
| Sep 30, 2023 | -143.80 Mn |
| Jun 30, 2023 | -143.60 Mn |
| Mar 31, 2023 | -143.14 Mn |
| Dec 31, 2022 | 148.41 Mn |
| Sep 30, 2022 | -141.98 Mn |
| Jun 30, 2022 | -138.80 Mn |
| Mar 31, 2022 | -137.69 Mn |
| Dec 31, 2021 | 64,000.00 |
| Sep 30, 2021 | 66,000.00 |